Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
Irene Marafini, Giovanni Monteleone Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence: Giovanni MonteleoneDipartimento di Medicina dei Sistemi, Università di Roma “Tor Vergata”, via Montpellier, 1, Rome 0013...
Guardado en:
Autores principales: | Marafini I, Monteleone G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8d23af80a2684fe7936e31495ba02cbc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metalloproteinases in Inflammatory Bowel Diseases
por: Marônek M, et al.
Publicado: (2021) -
Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A review of 740 patients in Fars province, Southern Iran.
por: John F.Mayberry
Publicado: (2013) -
Frequency of Oral Manifestation in Patients with Inflammatory Bowel Disease in Chile
por: Oviedo,C, et al.
Publicado: (2017) -
A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
por: Byron P. Vaughn
Publicado: (2021) -
Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A review of 740 patients in Fars province, Southern Iran
por: Murat Kekilli, et al.
Publicado: (2013)